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ABSTRACT
Earlier studies in the 1990s indicate that human immunodeficiency virus type 1 (HIV-1) subtype B has been
the predominant subtype among injecting drug users (IDUs) in Malaysia. More recent studies performed be-
tween 2003 and 2004, however, show a high prevalence of unique CRF01_AE/B intersubtype recombinants
among IDUs. To determine the subtype distribution among IDUs in Kuala Lumpur prior to the emergence
of CRF01_AE/B intersubtype recombinants, the gag–pol or the reverse transcriptase gene was sequenced from
IDUs who were diagnosed as HIV positive between 1993 and 2002. Subtype B was present at 50.0% followed
by CRF01_AE/B recombinant at 41.7%, with more CRF01_AE/B recombinants detected between 2000 and
2002. All CRF01_AE/B recombinants shared similar recombination patterns. Interestingly, we found that this
potential new candidate of circulating recombinant form (CRF) could have emerged as early as the mid-1990s.
The results showed evidence of changing HIV-1 molecular epidemiology toward the predominance of
CRF01_AE/B intersubtype recombinants among IDUs in Kuala Lumpur.
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THE EXTENSIVE DIVERSITY OF HIV-1 has significant impacton disease pathogenesis, long-term antiretroviral treatment,
and the development of an effective vaccine. Subtype infor-
mation is particularly important when clinical investigations on
antiretroviral drugs or candidate vaccines are initiated in a se-
lect population.
In Malaysia, very little information is available about the pre-
dominant HIV-1 subtypes circulating among injecting drug
users (IDUs). This is in spite of the fact that of the 64, 439 HIV
infections reported between 1986 and December 2004, 76%
were among IDUs. HIV-1 subtype B has been the predominant
subtype among IDUs since the early phase of the epidemic, fol-
lowed by CRF01_AE.1–3 Studies have shown that coexistence
of two or more subtypes circulating recombinant forms (CRFs)
in any population can lead to coinfection in individuals with
high-risk practices and therefore to the generation of an inter-
subtype recombinant strain.4–7 In our laboratory, we recently
demonstrated that the major circulating HIV-1 strain among
IDUs between 2003 and 2004 was CRF01_AE/B intersubtype
recombinants, which were also present in high prevalence in
other risk groups.8 These unique recombinant forms (URF)
shared similar recombination profiles in the protease and re-
verse transcriptase (RT) genes and led to evidence of the emer-
gence of a new CRF circulating in Kuala Lumpur, Malaysia.
However, recent data on the predominant subtype/CRF among
IDUs prior to the detection of CRF01_AE/B recombinants in
2003–2004 are still lacking. To demonstrate the changing mo-
lecular epidemiology of HIV-1 among IDUs, we studied the
subtype/CRF distribution among former IDU prison inmates di-
agnosed seropositive for HIV-1 between 1993 and 2002.
Plasma samples were collected from 36 consenting former
IDU prison inmates in Kuala Lumpur in 2004. These IDU sub-
jects were diagnosed while still incarcerated where HIV test-
ing upon admission to a prison is mandatory in Malaysia. All
inmates were antiretroviral naive at the time of sampling. HIV-
1 RNA was extracted and the nucleotide sequences of the par-
tial gag–pol gene encoding for protease and reverse transcrip-
tase were determined by nested PCR and direct sequencing
using a modified in-house genotypic drug resistance protocol
described previously.8 These nucleotide sequences were aligned
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FIG. 1. Neighbor-joining phylogenetic analysis and bootscan plots of (a) 24 gag–pol gene sequences (1.1 kb) and (b) 12 re-
verse transcriptase gene sequences (696 bp) of HIV-1 isolated from former IDUs in Kuala Lumpur, Malaysia. The Kimura two-
parameter method was used for estimating pairwise evolutionary distance and the reliability of the branching orders was assessed
by bootstrap analysis with 1000 replicates. Bootstrap values of more than 70% were shown at the nodes of the tree. The refer-
ence sequences used for multiple alignments were as follows: subtype A (A1.UG.U455 and A2.CD.97CDKFE4), subtype B
(B.FR.HXB2, B.US.JRFL, and B.CN.RL42), subtype C (C.IN.95IN21068 and C.BR.92BR025), subtype D (D.CD.NDK and
D.CD.ELI), and CRF01_AE (CRF01.TH.93TH253, CRF01.TH.CM240, and CRF01.CF.90CF402), subtype F (F1.BR.93BR020
and F2.CM.MP257), subtype G (G.SE.SE6165 and G.FI.HH8793-12.1), subtype H (H.CF.90CF056 and H.BE.V1997), subtype
J (J.SE.SE7887 and J.SE.SE7022), and subtype K (K.CD.EQTB11C and K.CM.MP535). SIVcpz reference isolates
(CPZ.CM.CAM5 and CPZ.US.CPZUS) were used as outgroup. Bootscan analysis was plotted using HIV-1 subtype B (RL42)
and CRF01_AE (CM240) as the putative parental strains, with subtype C (90BR025) as an outgroup. The bootstrap values were
calculated for a window of 200 bp moving in increments of 20 bp along the alignment.
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with selected HIV-1 strains of various reference subtypes ob-
tained from the Los Alamos HIV Database (http://www.
hiv.lanl.gov/). Phylogenetic analyses using the neighbor-join-
ing method were performed by MEGA version 2.1. Evolution-
ary distances were assessed using the Kimura two-parameter
model with a transition–transversion ratio of 2.0 and the relia-
bility of the branching orders was determined by bootstrap anal-
ysis with 1000 replicates.
From 36 subjects (21 Malay, 8 Indian, and 7 Chinese), a 1.1-
kb gag–pol gene (2195–3301 nt; HXB2 numbering) from 24
samples was successfully amplified and sequenced for analy-
sis. For the remaining 12 samples, a smaller fragment of 696
bp reverse transcriptase gene (2606–3301 nt) was analyzed as
an alternative.8 Phylogenetic analyses of these genes showed
that subtype B and CRF01_AE were present at 50.0% (n 
18/36) and 8.3% (n  3/36), respectively (Fig. 1). Most of the
subtype B and CRF01_AE isolates were clustered together with
reference strains from Thailand. CRF01_AE/B intersubtype re-
combinant was present at 41.7% (n  15/36), with 66.7% (n 
10/15) being present among Malay IDUs.
Bootscan analysis was performed on all CRF01_AE/B re-
combinants using SimPlot version 2.5. In the gag–pol gene,
three breakpoints were identified at 2395, 2555, and 2855 nt in
all 11 isolates (Fig. 1a). The small 5 subgenome of the gene
was estimated as subtype B until 2395 nt, followed by
CRF01_AE (2396–2555 nt) and subtype B (2556–2855 nt)
downstream. The 3 segment was estimated as CRF01_AE from
2856 nt to 3301 nt. In the shorter RT gene, one breakpoint at
2855 nt was identified in all four isolates with subtype B at the
5 subregion and CRF01_AE at the 3 segment after the break-
TABLE 1. SUBTYPE DISTRIBUTION AMONG 36 HIV-INFECTED FORMER INJECTING
DRUG USERS (IDUS) IN A PRISON IN KUALA LUMPUR, MALAYSIA
Date of first GenBank
positive HIV-1 test Subtype/CRF accession
Isolate Ethnicitya (month/year) (gag–pol gene)b number
04MYIDUA5 I 4/93 B DQ018345
04MYIDUA12 C 3/94 B DQ018351
04MYIDUB8 M 8/94 AE/B DQ018353
04MYIDUC22 M 1/96 AE/B DQ018362
04MYIDUA2 I 12/96 B DQ018343
04MYIDUA8 I 6/97 B DQ018348
04MYIDU26 M 3/98 AE/B AY887057
04MYIDUA10 C 5/98 B DQ018349
04MYIDU27 M 9/98 B AY887058
04MYIDU19 M 11/98 AE/B AY887043
04MYIDUC10 C 12/98 B DQ018361
04MYIDU8 M 3/99 B AY887046
04MYIDU9 M 4/99 B AY887047
04MYIDU10 M 4/99 AE/B AY887048
04MYIDUB11 M 5/99 AE DQ018354
04MYIDU12 C 5/99 AE AY887050
04MYIDUC3 I 2/00 AE/B DQ018357
04MYIDUC5 M 2/00 B DQ018359
04MYIDU18 C 2/00 B AY887051
04MYIDU20 I 2/00 AE/B AY887052
04MYIDUC9 I 2/00 AE/B DQ018360
04MYIDUC1 M 3/00 B DQ018355
04MYIDUC4 M 3/00 AE/B DQ018358
04MYIDU23 M 5/00 B AY887054
04MYIDUA7 C 7/00 AE/B DQ018347
04MYIDU24 I 8/00 AE AY887055
04MYIDUC2 M 11/00 AE/B DQ018356
04MYIDU25 M 11/00 B AY887056
04MYIDUA11 M 4/01 B DQ018350
04MYIDUD5 C 10/01 B DQ018364
04MYIDUD19 M 1/02 AE/B DQ018366
04MYIDUA14 M 5/02 B DQ018352
04MYIDUA3 M 8/02 AE/B DQ018344
04MYIDUD8 M 9/02 B DQ018365
04MYIDUA6 I 10/02 AE/B DQ018346
04MYIDUD2 M 12/02 AE/B DQ018363
aI, Indian; C, Chinese; M, Malay.
bB, subtype B; AE/B, CRF01_AE/B intersubtype recombinant; AE, CRF01_AE. Subtype/CRF assignment based on reverse
transcriptase (RT) gene is listed in italic type.
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point (Fig. 1b). These RT segments shared the same breakpoint
with the longer gag–pol gene at 2855 nt, indicating that these
isolates probably had the same recombination patterns if their
entire gag–pol gene was analyzed. Further analyses by RIP 2.0
(http://www.hiv.lanl.gov/) on all CRF01_AE/B isolates showed
that these mosaic viruses shared similar recombination pro-
files as in the bootscan plots (figures not shown). The sub-
type/CRF/URF distribution in all subjects is summarized in
Table 1. All CRF01_AE/B recombinants identified in this study
were similar to those recombinants previously described from
the protease and RT genes in our laboratory.8 However, the re-
combination breakpoints estimated in the current study may be
more accurate since the longer gag–pol gene was analyzed and
the bootstrap values were plotted with a larger window of 200
bp. Of all the CRF01_AE/B recombinants identified in Kuala
Lumpur, none of them shared any recombinant breakpoints with
CRF15_01B or other CRF01_AE/B recombinants described
elsewhere in the Southeast Asia region.4–7,9–11
In previous studies, subtype B was present as the major cir-
culating subtype at 85%, 55%, and 91% between the years
1992–1993, 1992–1996, and 1996–1997, respectively, with
CRF01_AE as the second major strain.1–3 In this study, we dem-
onstrated that subtype B was the major circulating subtype
among IDUs followed by CRF01_AE/B recombinant and
CRF01_AE. The predominance of subtype B, however, was not
high and the prevalence of CRF01_AE/B recombinants was in-
creasing with year of first positive HIV-1 testing, from 31.3%
(n  5/16) between 1993 and 1999 to 50.0% (n  10/20) be-
tween 2000 and 2002. Together with data from 2003–2004
where the prevalence of the CRF01_AE/B recombinant among
IDUs was about 83%,8 the HIV-1 molecular epidemiology
among IDUs in Kuala Lumpur has changed toward a predomi-
nance of CRF01_AE/B recombinants.4 Interestingly, the grad-
ual epidemiological shift from subtype B to CRF01_AE among
IDUs in Thailand was not observed in this study.12–15 Instead
of becoming “extinct,” CRF01_AE has in fact contributed to the
appearance of the newly identified CRF01_AE/B recombinant.
The earliest CRF01_AE/B recombinants were detected from
IDUs diagnosed in 1994 and later in 1996, suggesting that these
recombinants could have emerged in the population as early as
the mid-1990s. Since all samples in this study were collected
in 2004, the possibility of the subjects being multiply exposed
by injecting drug use (or by a different route) leading to inter-
subtype superinfections cannot be ruled out.16 The existence of
the CRF01_AE/B recombinant in the 1990s might have been
overlooked in previous studies, which focused mainly on the
env or gag gene for classifications.1–3 Molecular study on
archival samples of recent seroconverters in the 1990s would
therefore determine the actual year of emergence of the
CRF01_AE/B intersubtype recombinant in Kuala Lumpur.
This study provides evidence of the epidemiological shift
of HIV-1 among IDUs in Kuala Lumpur over the past decade.
The reasons for such evolution are not clearly understood.
However, the emergence of the CRF01_AE/B intersubtype
recombinant at high prevalence suggests that the recombinant
strains might have selective advantages in the viral patho-
genicity and/or tranmission fitness among IDUs over the two
parental strains. The emergence of the new CRF candidate
clearly points to the high genetic variability of HIV-1 among
IDUs in Kuala Lumpur.
SEQUENCE DATA
Nucleotide sequences were submitted to GenBank under ac-
cession numbers as shown in Table 1.
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